The Chronic Plaque Psoriasis Market report provides an edge while developing business strategies, by understanding trends shaping and driving the global psoriasis market.
Psoriasis is recognized as the most prevalent immune-mediated inflammatory disease, involving skin and joints and associated with abnormalities of other systems. Even though the condition is not life-threatening, it is difficult to treat and response rates vary widely.
The key players of Chronic Plaque Psoriasis report are Amgen, Janssen, Abbvie, Novartis, AstraZeneca/Bausch Health, Eli Lilly, Sun Pharmaceutical, UCB Inc. LEO Pharma, and many others
Download free sample copy- https://www.delveinsight.com/sample-request/chronic-plaque-psoriasis-market
Regions Analysis
Chronic Plaque Psoriasis Market: Treatment
Treatment modalities are chosen based on disease severity, relevant comorbidities, patient preference (including cost and convenience), efficacy, and evaluation of individual patient response. Although there is no cure for psoriasis, there are multiple effective treatment options, and topical therapy is the standard of care for treatment. Mild to moderate psoriasis can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy. Systemic treatment, which includes immunosuppressants and biologics, are required in moderate-to-severe cases.
Chronic Plaque Psoriasis Market: Report
In recent years, several technologies have been developed to enhance the efficacy and safety of topical drug therapy. Furthermore, new drug carriers offer the opportunity to introduce new molecules into topical psoriasis therapy. For these purposes, vesicular drug delivery systems including niosomes, proniosomes, liposomes and transferosomes, nonvesicular drug delivery systems such as foams, gels, and nanoparticles have been developed.
Chronic Plaque Psoriasis Market: Insights
A range of agents is available for the symptomatic treatment of psoriasis. Patients with mild-to-moderate psoriasis usually receive topical treatments that modulate gene transcription, inhibit cell proliferation and promote keratinocyte differentiation. These cases can be treated topically with a combination of glucocorticoids, vitamin D analogues, and phototherapy.
Chronic Plaque Psoriasis Market: Outlook
Biologics have emerged as highly potent treatment options in patients for whom traditional systemic therapies fail to achieve an adequate response, are not tolerated owing to adverse effects, or are unsuitable owing to comorbidities.
Chronic Plaque Psoriasis Market: Forecast
Considered the cornerstone of topical treatment, corticosteroids are often well tolerated and effective for patients with mild psoriasis. Calcipotriol, a vitamin D3 analogue, is a first-line topical agent for the treatment of plaque psoriasis and moderately severe scalp psoriasis.
Following is the Table of Content of the report
1. Key Insights
2. Executive Summary of Chronic Plaque Psoriasis
3. Competitive Intelligence Analysis for Chronic Plaque Psoriasis
4. Chronic Plaque Psoriasis: Market Overview at a Glance
5. Chronic Plaque Psoriasis: Disease Background and Overview
6. Patient Journey
7. Chronic Plaque Psoriasis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Chronic Plaque Psoriasis Treatment
11. Marketed Products
13. Chronic Plaque Psoriasis: Seven Major Market Analysis
13.3. Chronic Plaque Psoriasis Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Chronic Plaque Psoriasis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Chronic Plaque Psoriasis Market: Report Scope
Why should you buy this report?
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Yash BhardwajEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/